Form 13-F position report

INTUITIVE SURGICAL INC

Reported by VALICENTI ADVISORY SERVICES INC

ISRG CUSIP 46120E602 Manager CIK 0001080201

Reported 29,686 shares, down 114 (0.4%) from the prior quarter.

Reported value 1.9%; share count -0.4% vs. the prior quarter.

Reduced
% of reported 13F value 2.27% This manager · Q3 2026
Shares 29,686 Quarter-end amount reported
Reported value $12,071,000 Fair value at quarter end
Consecutive quarters held 54 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 11898000
2022-03-31 10209000
2022-06-30 7044000
2022-09-30 6577000
2022-12-31 8866000
2023-03-31 8714000
2023-06-30 11536000
2023-09-30 9788000
2023-12-31 11272000
2024-03-31 13153000
2024-06-30 14438000
2024-09-30 15366000
2024-12-31 15804000
2025-03-31 13790000
2025-06-30 15013000
2025-09-30 13400000
2025-12-31 16892000
2026-03-31 13704000
2026-06-30 11851000
2026-09-30 12071000

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for INTUITIVE SURGICAL INC held by VALICENTI ADVISORY SERVICES INC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Reduced 29,686 -114 (-0.4%) 2.27% $12,071,000 2026-10-23
Q2 2026 Added 29,800 +72 (0.2%) 2.24% $11,851,000 2026-07-16
Q1 2026 Reduced 29,728 -98 (-0.3%) 2.99% $13,704,000 2026-04-14
Q4 2025 Reduced 29,826 -136 (-0.5%) 3.53% $16,892,000 2026-01-16
Q3 2025 Added 29,962 +2,335 (8.5%) 2.87% $13,400,000 2025-10-17
Q2 2025 Reduced 27,627 -217 (-0.8%) 3.51% $15,013,000 2025-07-16
Q1 2025 Reduced 27,844 -2,435 (-8.0%) 3.55% $13,790,000 2025-04-23
Q4 2024 Reduced 30,279 -1,000 (-3.2%) 3.94% $15,804,000 2025-01-23
Q3 2024 Reduced 31,279 -1,176 (-3.6%) 3.95% $15,366,000 2024-10-23
Q2 2024 Reduced 32,455 -503 (-1.5%) 3.88% $14,438,000 2024-07-23
Q1 2024 Reduced 32,958 -454 (-1.4%) 3.66% $13,153,000 2024-04-23
Q4 2023 Reduced 33,412 -77 (-0.2%) 3.43% $11,272,000 2024-01-16
Q3 2023 Reduced 33,489 -247 (-0.7%) 3.34% $9,788,000 2023-10-18
Q2 2023 Reduced 33,736 -375 (-1.1%) 3.66% $11,536,000 2023-07-12
Q1 2023 Added 34,111 +698 (2.1%) 2.9% $8,714,000 2023-04-20
Q4 2022 Reduced 33,413 -1,677 (-4.8%) 3.23% $8,866,000 2023-01-17
Q3 2022 Reduced 35,090 -3 (0.0%) 2.4% $6,577,000 2022-10-18
Q2 2022 Added 35,093 +1,252 (3.7%) 2.3% $7,044,000 2022-07-19
Q1 2022 Added 33,841 +726 (2.2%) 2.68% $10,209,000 2022-04-20
Q4 2021 Added 33,115* +43 (0.1%) 2.96% $11,898,000 2022-01-21
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

2412 managers reported INTUITIVE SURGICAL INC for Q3 2026.

Managers reporting INTUITIVE SURGICAL INC in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Reduced 29,561,783 -462,865 0.18% $12,020,707,694 9 qtrs
VANGUARD CAPITAL MANAGEMENT LLC Reduced 23,128,331 -2,768 0.2% $9,404,673,235 3 qtrs
STATE STREET CORPORATION Added 16,173,422 +110,382 0.19% $6,576,598,588 54 qtrs
Invesco Ltd Added 12,017,482 +173,919 0.38% $4,886,668,693 54 qtrs
PRICE T ROWE ASSOCIATES INC MD Reduced 9,945,424 -1,311,146 0.41% $4,044,108,000 54 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 8,542,334 +7,567 0.18% $3,458,144,928 54 qtrs
Capital World Investors Added 8,443,500 +700,819 0.42% $3,433,529,409 54 qtrs
MORGAN STANLEY Added 7,746,501 +1,185,179 0.16% $3,149,960,855 54 qtrs
VANGUARD PORTFOLIO MANAGEMENT LLC Added 7,436,357 +193,093 0.14% $3,023,845,847 3 qtrs
JPMorgan Chase & Co Added 4,753,008 +521,975 0.11% $1,959,096,039 54 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
October 23, 2026
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
0
Shared
0
None
29,686

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.